Physician

Robert O Satriale, MD

According to 2025 Medicare claims, Robert Satriale, MD (NPI: 1154321719) practices pulmonary disease in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN, INC (NPI: 1104309889; TIN: 831002191) and primary practice location at 19460-6127.

Satriale's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 578 traditional Medicare patients, billed 5,995 HCPCS/CPT codes, and received $219,294 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,411 prescription claims across 398 beneficiaries totaling $2,962,883 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 4,596 claims. Open Payments data shows 17 records totaling $492. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $328,460 to $219,294. In contrast, Part D prescription costs have risen steadily, from $1,072,326 to $2,962,883. For DME billing, reported payments rose steadily, from $121,513 to $211,811.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	994	3,922	$328,460
2016	955	3,976	$286,389
2017	1,111	4,815	$347,876
2018	1,047	4,815	$357,879
2019	1,015	4,201	$298,780
2020	803	2,658	$206,209
2021	909	2,909	$247,522
2022	609	1,806	$115,165
2023	536	3,737	$166,611
2024	578	5,995	$219,294

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	375	2,772	$1,072,326
2016	433	3,094	$1,236,356
2017	454	3,653	$1,387,087
2018	430	3,567	$1,436,660
2019	453	3,702	$1,448,267
2020	432	3,547	$1,547,398
2021	443	3,202	$1,872,497
2022	505	3,128	$1,688,214
2023	370	2,751	$1,725,973
2024	398	3,411	$2,962,883

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,236	2,879	$140,109
2016	1,478	3,777	$167,498
2017	1,740	4,295	$179,712
2018	1,794	4,346	$212,603
2019	1,815	4,580	$252,415
2020	1,912	4,790	$281,900
2021	1,601	3,836	$207,730
2022	1,578	3,906	$169,920
2023	1,439	3,752	$200,141
2024	1,746	4,596	$264,169

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	36	36	$165
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	102	121	$143
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	144	144	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	323	495	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	37	39	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	97	2,947	$1,278,260
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	268	9,300	$195,854
Dupixent Pen	Dupilumab	42	1,190	$162,180
Zemaira	Alpha-1-Proteinase Inhibitor	14	378	$144,548
Xolair	Omalizumab	14	364	$106,859

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	75	$56,181
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	47	368	$26,160
A7032	Cushion for use on nasal mask interface, replacement only, each	N	100	216	$20,461
A7031	Face mask interface, replacement for full face mask, each	N	105	230	$20,304
A7030	Full face mask used with positive airway pressure device, each	N	104	235	$19,886

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$492	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert O. Satriale, MD?

Tedicare shows public-source Medicare data for Robert O. Satriale, MD (NPI 1154321719), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert O. Satriale, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert O. Satriale, MD?

Robert O. Satriale, MD is linked to TEMPLE FACULTY PRACTICE PLAN, INC (billing NPI 1104309889) in the available physician profile data.

Does Robert O. Satriale, MD have Open Payments data?

Robert O. Satriale, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.